Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
21.48
+0.36 (1.70%)
Nov 16, 2026, 3:20 PM EST - Market open

Assembly Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
67.0172.328.527.16-6.25
Revenue Growth
80.18%153.52%298.16%---92.09%
Gross Profit
-0.297.49-27.41-41.74-69.08-63.9
Operating Income
-21.33-12.12-45.42-64.65-93.01-92.4
Net Income
-11.1-6.12-40.18-61.23-93.09-129.86
Earnings Per Share
-0.60-0.55-6.69-13.38-23.08-36.00
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
314.26248.11112.08130.2591.61174.6
Total Debt
2.212.633.092.343.476.48
Net Cash (Debt)
312.06245.48108.99127.9188.15168.12
Net Cash Growth
35.79%125.23%-14.79%45.11%-47.57%-18.50%
Net Cash Per Share
16.7521.9018.1527.9421.8546.61

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-40.51-41.09-51.1222.74-84.46-93.4
Capital Expenditures
-0.16-0.07-0.03-0.26-0.1-3.1
Free Cash Flow
-40.68-41.16-51.1522.49-84.57-96.49
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-0.43%10.36%-96.12%---
Operating Margin
-31.83%-16.76%-159.26%-902.50%--1477.42%
Pretax Margin
-16.57%-8.47%-139.72%-854.32%--2116.82%
Profit Margin
-16.57%-8.47%-140.87%-854.78%--2076.35%
FCF Margin
-60.70%-56.93%-179.33%313.95%--1542.88%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
---2.40--
PS Ratio
6.647.443.527.53-17.83